Nektar Therapeutics reported $-90393000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
ALKERMES ALKS:US $ -35.9M 36.78M
Amgen AMGN:US $ 1476M 423M
Astrazeneca AZN:US $ 386M 733M
Baxter International BAX:US $ 71M 167M
Biocryst Pharmaceuticals BCRX:US $ -74.2M 56.42M
Biogen BIIB:US $ 303.8M 64.4M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Cara Therapeutics CARA:US $ -27749000 5.63M
Dr.Reddys Laboratories DRRD:IN IR 970M 6123M
Eisai 4523:JP Y -12403M 26575M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Exelixis EXEL:US $ 68.57M 26.59M
Gilead Sciences GILD:US $ 19M 363M
GlaxoSmithKline GSK:LN 1802M 1053M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Immunogen IMGN:US $ -24.14M 13.03M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Ironwood Pharmaceuticals IRWD:US $ 38.8M 2.57M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Macrogenics MGNX:US $ -66.44M 8.42M
Merk MRK:US $ 4310M 552M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Pfizer PFE:US $ 7863M 4470M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Seattle Genetics SGEN:US $ -136.49M 38.13M
Takeda 4502:JP Y -11358M 69127M
Teva Pharmaceutical TEVA:IT -955000000 797M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 37.99M 525.86M